- Home
- ASTS vs AXSM Comparison
ASTS vs AXSM Comparison
Compare ASTS & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTS
- AXSM
- Stock Information
- Founded
- ASTS 2019
- AXSM 2012
- Country
- ASTS United States
- AXSM United States
- Employees
- ASTS N/A
- AXSM N/A
- Industry
- ASTS Telecommunications Equipment
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- ASTS Consumer Discretionary
- AXSM Health Care
- Exchange
- ASTS Nasdaq
- AXSM Nasdaq
- Market Cap
- ASTS 4.1B
- AXSM 4.2B
- IPO Year
- ASTS N/A
- AXSM 2015
- Fundamental
- Price
- ASTS $28.64
- AXSM $137.75
- Analyst Decision
- ASTS Strong Buy
- AXSM Strong Buy
- Analyst Count
- ASTS 5
- AXSM 14
- Target Price
- ASTS $40.04
- AXSM $158.93
- AVG Volume (30 Days)
- ASTS 14.2M
- AXSM 1.1M
- Earning Date
- ASTS 03-03-2025
- AXSM 02-18-2025
- Dividend Yield
- ASTS N/A
- AXSM N/A
- EPS Growth
- ASTS N/A
- AXSM N/A
- EPS
- ASTS N/A
- AXSM N/A
- Revenue
- ASTS $2,500,000.00
- AXSM $385,693,000.00
- Revenue This Year
- ASTS N/A
- AXSM $45.18
- Revenue Next Year
- ASTS $4,467.90
- AXSM $65.22
- P/E Ratio
- ASTS N/A
- AXSM N/A
- Revenue Growth
- ASTS N/A
- AXSM 42.53
- 52 Week Low
- ASTS $1.97
- AXSM $64.11
- 52 Week High
- ASTS $39.08
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- ASTS 56.14
- AXSM 74.55
- Support Level
- ASTS $27.05
- AXSM $124.04
- Resistance Level
- ASTS $33.55
- AXSM $130.52
- Average True Range (ATR)
- ASTS 2.88
- AXSM 5.78
- MACD
- ASTS 0.49
- AXSM 1.11
- Stochastic Oscillator
- ASTS 66.58
- AXSM 96.07
About ASTS AST SpaceMobile Inc.
AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers and finally bringing broadband to the billions who remain unconnected. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.